ARTICLE | Company News
Quest Pharma dermatology, cancer news
February 9, 2009 8:00 AM UTC
Quest hired Loewen, Ondaatje, McCutcheon Ltd. to assist in a review of strategic alternatives. The company's lead compound, SL017, is in Phase II testing to remove unwanted hair, with data expected i...